no more tirzepatide The FDA has declared an end to the two-year shortage of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes drug Mounjaro — meaning that far people could FDA Announces End To Compounded

Conformational transitions of the pituitary adenylate cyclase-activating polypeptide receptor, a human class B GPCR

More The Mysteries of Blood Sugar: Beyond Food Blood Glucose and Hunger: Decoding the Intimate Relationship Stress and Cortisol: The Missing Piece to Your Weight Loss and Blood Sugar Puzzle Waking Up with High Blood Sugar

Currently, phase II trial results of fibroblast growth factor 21 (FGF21) and phase III trial results of resmetirom and pioglitazone are encouraging

The injection can be administered at any time on the scheduled day, and patients do not need to inject at the same time each weekonly the same day matters for maintaining steady-state drug levels

Institutional experience with new antidiabetic drugs in kidney transplant